RxDoctor Payments Data

Jennifer Stanhope, NP

Gerontology · Worcester, MANPI 1376927400

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Acadia Pharmaceuticals Inc accounts for 64.4% of it on its own, with 5 other manufacturers making up the rest.

$495in general payments, 2019–2025

Across 15 payments — averaging $33.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$319
  • AstraZeneca$118
  • Esperion Therapeutics, Inc.$17
  • GSK$16
  • Sunovion Pharmaceuticals Inc.$15
  • Lilly USA, LLC$12

What the payments were for

  • Food & beverage$495100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$495 in reported general payments places this provider in the 65th percentile of 168 gerontology providers in Massachusetts.

See all gerontology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$122,299
Medicare patients
271
Services billed
1,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$23,564
OxycontinOxycodone Hcl21$4,801
Fentanyl19$4,693
Oxycodone Hcl70$1,422
Lorazepam110$1,259
Galantamine Hbr40$1,118
Atorvastatin Calcium67$952
Aripiprazole41$777
Metoprolol Succinate48$777
Potassium Chloride34$747
Memantine Hcl34$725
Levothyroxine Sodium70$714
Simvastatin107$706
Tramadol Hcl86$620
Divalproex Sodium36$554

Paid to pharmacies, not to this prescriber.

Other gerontology in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →